Snippet Search

Searching 12,047,506 documents.
Discover how a particular term or phrase is used in scientific literature

Showing 1 to 25 of 59 matching articles

Results per page:

... Summary The alkylating antitumor agents  mitomycin 
Cardiotoxicity of mitomycin A, mitomycin C, and sevenN7 analogs in vitro
Cardiotoxicity of mitomycin A, mitomycin C, and sevenN7 analogs in vitro
Dorr, Robert T.; Shipp, Nancy G.; Liddil, James D.; Iyengar, Bhashyam S.; Kunz, Kenneth R.; Remers, William A.
A (MMA), ...
... Summary The pharmacokinetics of  mitomycin 
Pharmacokinetics of mitomycin C in patients after bolus injection and chemobolisation of the hepatic artery with Spherex starch particles
Pharmacokinetics of mitomycin C in patients after bolus injection and chemobolisation of the hepatic artery with Spherex starch particles
Czejka, M. J.; Jäger, W.; Schüller, J.
C after chemobolisation of the common ...
... treatment with the DNA synthesis inhibitor,  mitomycin 
Retroviral Vectors as Insertional Mutagens
Retroviral Vectors as Insertional Mutagens
Gäken, Joop; Farzaneh, Farzin
C. ...
... water, group 2 received intraoperative  mitomycin 
Intraoperative and post operative treatment with 5-Fluorouracil and mitomycin-c: long term effects in vivo on subconjunctival and scleral fibroblasts
Intraoperative and post operative treatment with 5-Fluorouracil and mitomycin-c: long term effects in vivo on subconjunctival and scleral fibroblasts
Khaw, Peng T.; Sherwood, Mark B.; William Doyle, J.; Fran Smith, M.; Grierson, Ian; McGorray, Sue; Schultz, Gregory S.
-c 0.2 mg/ml for 5 minutes, group 3 ...
... when their production was induced with  mitomycin 
Genetic Determinants for Microcin H47, an Escherichia Coli Chromosome-Encoded Antibiotic
Genetic Determinants for Microcin H47, an Escherichia Coli Chromosome-Encoded Antibiotic
Laviña, M.; Gaggero, C.
, and as microcins when they were not ...
... of the commonly prescribed 28-day MVP (  mitomycin 
The use of granulocyte colony-stimulating factor to shorten the interval between cycles of mitomycin C, vindesine, and cisplatin chemotherapy in non-small-cell lung cancer
The use of granulocyte colony-stimulating factor to shorten the interval between cycles of mitomycin C, vindesine, and cisplatin chemotherapy in non-small-cell lung cancer
Takada, Minoru; Fukuoka, Masahiro; Ariyoshi, Yutaka; Furuse, Kiyoyuki; Niitani, Hisanobu; Ota, Kazuo; Motomiya, Masakichi; Hasegawa, Kouichi; Tominaga, Keigo; Kuriyama, Takayuki; Yoshida, Kiyokazu; Kimura, Hitoshi; Kurita, Yuzo; Nakajima, Shigenori; Nakai, Jun; Ohta, Mituo; Yamamoto, Hidehiko
C, vindesine, and cisplatin) regimen in ...
... and thereafter to the promoter carcinogen  mitomycin 
Inhibition of two-step urinary bladder carcinogenesis by the somatostatin analogue RC-160
Inhibition of two-step urinary bladder carcinogenesis by the somatostatin analogue RC-160
Szende, B.; Juhasz, E.; Lapis, K.; Schally, A. V.
C (0.08 mg per animal per week) ...
... The drugs tested included the antibiotic  mitomycin 
Nonimmunological release of histamine from rat mast cells elicited by antineoplastic agents: effect of drug combinations
Nonimmunological release of histamine from rat mast cells elicited by antineoplastic agents: effect of drug combinations
Botana, L. M.; Arnaez, E.; Vieytes, M. R.; Alfonso, A.; Louzao, M. C.
; the anthracyclines daunorubicin, ...
... and chemotherapy with 5-Fluorouracil and  Mitomycin 
Combined radiation and chemotherapy for epidermoid carcinoma of the anal canal
Combined radiation and chemotherapy for epidermoid carcinoma of the anal canal
Schneider, I. H. F.; Grabenbauer, G. G.; Reck, T.; Köckerling, R.; Sauer, R.; Gall, F. P.
C. ...
... cells became markedly augmented after  mitomycin 
Correlation of eosinophilia with clinical response in patients with advanced carcinoma treated with low-dose recombinant interleukin-2 and mitomycin C
Correlation of eosinophilia with clinical response in patients with advanced carcinoma treated with low-dose recombinant interleukin-2 and mitomycin C
Arinaga, Shinya; Karimine, Nobuya; Takamuku, Kiyoshi; Nanbara, Shigeru; Inoue, Hiroshi; Abe, Ryoji; Watanabe, Daisuke; Matsuoka, Hideo; Ueo, Hiroaki; Akiyoshi, Tsuyoshi
C administration, we designed a treatment ...
... All but 1 patient also received i.p.  mitomycin 
Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma
Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma
Markman, Maurie; Kelsen, David
. ...
... target cells to cisplatin, doxorubicin, or  mitomycin 
Additive effects of antitumor drugs and lymphokine-activated killer cell cytotoxic activity in tumor cell killing determined by lactate-dehydrogenase-release assay
Additive effects of antitumor drugs and lymphokine-activated killer cell cytotoxic activity in tumor cell killing determined by lactate-dehydrogenase-release assay
Kawai, Koji; Sasaki, Tetsuji; Saijo-Kurita, Kaoru; Akaza, Hideyuki; Koiso, Kenkichi; Ohno, Tadao
C, the drugs were washed off and LAK cells ...
... criteria. The control group received  mitomycin 
Randomized, controlled study on adjuvant immunochemotherapy with PSK® in curatively resected colorectal cancer
Randomized, controlled study on adjuvant immunochemotherapy with PSK® in curatively resected colorectal cancer
Mitomi, Toshio; Tsuchiya, Shuji; Iijima, Noboru; Aso, Koichi; Suzuki, Kaisuke; Nishiyama, Kiyoshi; Amano, Tomishige; Takahashi, Toshitake; Murayama, Norihisa; Oka, Hisashi; Oya, Kazumitsu; Noto, Takashi; Ogawa, Nobuya
C intravenously on the day of and the day ...
... trabeculectomies (TE) were performed using  mitomycin 
Mitomycine, suterelysis and hypotony
Mitomycine, suterelysis and hypotony
Caroline Geijssen, H.; Greve, Erik L.
as a fibrosisinhibitor. ...
... die postoperativ 4mal täglich 0,04%  Mitomycin 
Postoperative topische Mitomycin Behandlung bei Pterygien
Postoperative topische Mitomycin Behandlung bei Pterygien
Hausmann, N.; Diem, W.
C Augentropfen 14 Tage lang als ...
... (ADR) at 20 mg/m2 every 4 weeks and  mitomycin 
Management of patients with unresectable liver metastases from colorectal and gastric cancer employing an implantable port system
Management of patients with unresectable liver metastases from colorectal and gastric cancer employing an implantable port system
Arai, Yasuaki; Endo, Tokiko; Sone, Yasuhiro; Tohyama, Norihiro; Inaba, Yoshitaka; Kohno, Satoru; Ariyoshi, Yutaka; Kido, Choichiro
C (MMC) at 2.7 mg/m2 every 2 weeks were ...
... of 20 patients were treated with 3 mg/m2  mitomycin 
Combination chemotherapy for advanced urothelial-tract carcinoma
Combination chemotherapy for advanced urothelial-tract carcinoma
Sahashi, Masafumi; Ono, Yoshinari; Matsuura, Osamu; Ohshima, Shinichi; Fukushima, Masanori
C and 300 mg/m2 cyclophosphamide given ...
... Gy); neoadjuvant chemotherapy (vinblastine,  mitomycin 
A randomized trial of neoadjuvant vs concomitant chemotherapy vs radiotherapy alone in the treatment of stage IV head and neck squamous cell carcinoma
A randomized trial of neoadjuvant vs concomitant chemotherapy vs radiotherapy alone in the treatment of stage IV head and neck squamous cell carcinoma
Salvajoli, J. V.; Morioka, H.; Trippe, N.; Kowalski, L. P.
, cisplatin, and bleomycin) and ...
... found in human skin fibroblasts following  mitomycin 
May ultraviolet light-induced ornithine decarboxylase response in mitotic and postmitotic human skin fibroblasts serve as a marker of aging and differentiation?
May ultraviolet light-induced ornithine decarboxylase response in mitotic and postmitotic human skin fibroblasts serve as a marker of aging and differentiation?
Niggli, Hugo J.; Ftancz, Pal I.
-C (MMC) treatment characteristic ...
... included the systemic administration of  mitomycin 
Effect of intra-hepatoarterial infusion of MMC and CDDP for gastric cancer patients with liver metastases
Effect of intra-hepatoarterial infusion of MMC and CDDP for gastric cancer patients with liver metastases
Yonemura, Yutaka; Matuki, Nobuo; Sakuma, Hiroshi; Katayama, Kannji; Sawa, Toshiharu; Fujimura, Takashi; Ohyama, Shigekazu; Miwa, Kouichi; Miyazaki, Ituo; Tanaka, Motohiro; Sasaki, Takuma
C (MMC) (39 patients), an ...
... cisplatin (CDDP), etoposide (VP-16), and  mitomycin 
The succinate dehydrogenase inhibition test for evaluating biopsy specimens and resected tumors of advanced gastric cancer
The succinate dehydrogenase inhibition test for evaluating biopsy specimens and resected tumors of advanced gastric cancer
Kimura, Hironobu; Yonemura, Yutaka; Ohyama, Shigekazu; Tsugawa, Kouichirou; Kinoshita, Kazuo; Ninomiya, Itasu; Kosaka, Takeo; Miwa, Kouichi; Miyazaki, Itsuo; Tanaka, Motohiro; Sasaki, Takuma
C (MMC). ...
... Summary A  mitomycin 
The role of NAD(P)H: quinone oxidoreductase in mitomycin C- and porfiromycin-resistant HCT 116 human colon-cancer cells
The role of NAD(P)H: quinone oxidoreductase in mitomycin C- and porfiromycin-resistant HCT 116 human colon-cancer cells
Pan, Su-shu; Akman, Steven A.; Forrest, Gerald L.; Hipsher, Carlyn; Johnson, Robin
C (MMC)- and porfiromycin (PFM)-resistant ...
... synthesised cytotoxic drug (doxorubicin and  mitomycin 
The effect of angiotensin II on tumor blood flow and the delivery of microparticulate cytotoxic drugs
The effect of angiotensin II on tumor blood flow and the delivery of microparticulate cytotoxic drugs
Kerr, D. J.; Goldberg, J. A.; Anderson, J. R.; Wilmott, N.; Whatelely, A. T.; McArdle, C. S.; Mckillop, J.
C) containing spheres 40 pm in diameter, ...
... das FAM-Schema (5-Fluorouracil, Adriamycin,  Mitomycin 
Indikationen und Ergebnisse der second-look-Operation bei chemotherapierten Patienten mit metastasiertem Magenkarzinom
Indikationen und Ergebnisse der second-look-Operation bei chemotherapierten Patienten mit metastasiertem Magenkarzinom
Weh, H. J.; Meyer-Pannwitt, U.; Henne-Bruns, D.; Hossfeld, D. K.
C) angesehen, das mit einer Remissionsrate ...
... buffered saline solution). Combination with  mitomycin 
Cytostatic effect of different strains of Bacillus Calmette-Guérin on human bladder cancer cells in vitro alone and in combination with mitomycin C and Interferon-α
Cytostatic effect of different strains of Bacillus Calmette-Guérin on human bladder cancer cells in vitro alone and in combination with mitomycin C and Interferon-α
Rajala, P.; Kaasinen, E.; Rintala, E.; Jauhiainen, K.; Nurmi, M.; Alfthan, O.; Lähde, M.
C or interferon-α-2b potentiated the ...